Sort
23,748 grants matching “melanoma”
Developmental Funds
$454,504Dario C. Altieri · Wistar Institute · P30 · FY2017 · CA
Core D: Pathology and BioImaging
$454,463Carl D Morrison · Roswell Park Cancer Institute Corp · P01 · FY2023 · CA
Role of Polo-Like Kinase-1 in Melanocytic Transformation
$454,433Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2019 · AR
Determine the Microphthalmia Transcription Factor (MITF)-regulated cell rewiring mechanisms in lethal prostate cancer
$454,404Josep Maria Domingo-Domenech · Mayo Clinic Rochester · R01 · FY2025 · CA
Modeling to Minimize Detection Bias in Cancer Risk Prediction Studies
$454,280Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Targeting Gq pathway in uveal melanoma
$454,204Xu Chen · University Of California, San Francisco · R01 · FY2022 · CA
Vanderbilt Clinical Oncology Research Career Development Award
$454,075Wendy K Rathmell · Vanderbilt University Medical Center · K12 · FY2016 · CA
Project 2: Spatial Architecture of Tumor-Mediated Immunosuppression
$454,052Garry P Nolan · Stanford University · U54 · FY2019 · CA
Tumor Cell Dependence on Host Metabolism
$454,038Eileen White · Rutgers, The State Univ Of N.J. · R01 · FY2021 · CA
Mechanisms of cell death in cutaneous melanoma
$453,931Andrew E Aplin · Thomas Jefferson University · R01 · FY2024 · CA
Bioluminecence-activated photodynamic therapy of breast cancer
$453,878Seok H Yun · Massachusetts General Hospital · R01 · FY2016 · CA
Bioluminecence-activated photodynamic therapy of breast cancer
$453,878Seok H Yun · Massachusetts General Hospital · R01 · FY2015 · CA
Bioluminecence-activated photodynamic therapy of breast cancer
$453,878Seok H Yun · Massachusetts General Hospital · R01 · FY2017 · CA
INTEGRINS AND OCULAR ANGIOGENESIS
$453,812Scripps Research Institute · R01 · FY2000 · EY
Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance
$453,702Willy Hugo · University Of California Los Angeles · R01 · FY2023 · CA
VEGFs in tumor lymphatic metastasis
$453,456Harold Fisher Dvorak · Beth Israel Deaconess Medical Center · R01 · FY2011 · CA
In vivo efficacy evaluation of novel melanoma actives
$453,399Dmitriy Minond · Nova Southeastern University · R15 · FY2020 · CA
Pannoramic 250 BF Flash Tissue Microarray system
$453,300Kelli L. Boyd · Vanderbilt University · S10 · FY2014 · OD
The Role of Schwann Cells in the Progression of Melanoma
$453,195Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Mechanism of Chronic Alcohol Consumption-induced Cancer-Associated Cachexia
$453,000Hui Zhang · Washington State University · R15 · FY2016 · AA
NGS-based analysis of mutation signatures during the translesion synthesis
$453,000Tomohiko Sugiyama · Ohio University Athens · R15 · FY2020 · ES
Disclosing Genomic Incidental Findings in a Cancer Biobank: An ELSI Experiment
$452,960Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2015 · CA
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$452,938Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Determine the Microphthalmia Transcription Factor (MITF)-regulated cell rewiring mechanisms in lethal prostate cancer
$452,824Josep Maria Domingo-Domenech · Mayo Clinic Rochester · R01 · FY2023 · CA
Phase I/II study of topical agents for chemoprevention
$452,786David S Alberts · University Of Arizona · P01 · FY2006 · CA